Premium high-scrutiny publishing
Regulated Brands Do Not Need Weaker Stories
Claim-sensitive news needs stronger evidence, not louder promises. MBK plans the search angle and manages a publisher-reviewed release around the facts your business can support. Distribution starts at $2,000. Every project requires prequalification before payment.
Why regulated work starts higher
The job is not to make the loudest possible claim. It is to preserve the strongest commercial truth that the evidence, company authorization, and selected publisher can support.
The client goal, search question, source material, and publisher fit are assessed together before a route is chosen.
See the general-business package comparison for route context. Claim-sensitive projects require a separate fit review; the higher price covers deeper planning and source work, not expert review or publisher approval.
- Supplement News Distribution — $2,000
- Global Supplement Distribution — $3,000
- Regulated Wellness Market Distribution — $4,500
Evidence-led release production is an optional $1,250. Complete production-and-distribution prices are $3,250, $4,250, or $5,750.
These tier names describe the level of planning and distribution work; they do not promise a named publisher. MBK confirms the exact publisher route, category eligibility, geographic scope, included distribution, and final order in writing before payment. If no suitable route accepts the proposed announcement and claims, we do not sell the package.
The premium is for the additional work and risk control required before submission:
- Product and company identity verification
- Goal-led keyword opportunity and reader-question planning
- News-event and eligibility screening
- Label, source, and evidence intake
- Claim classification and prohibited-claim screening
- Quote and credential authorization
- Publisher-route preparation
- Additional review and revision time
- A complete Publication Record after acceptance
The higher price does not buy permission to publish prohibited health claims. It buys the work required to build a defensible search asset without surrendering the commercial point of the story.
The result we pursue: an accepted public announcement that targets a useful search intent, sends the right reader to the right next page, and gives the company a credible source it can continue using after launch day.
What May Be Newsworthy
- A genuinely new product with finalized, supportable facts
- A manufacturing, distribution, retail, or research partnership
- A verified certification or quality milestone
- An authorized original survey or report
- A company expansion, appointment, funding event, or measurable milestone
- A material label, packaging, or business update that can be stated accurately
Routine marketing claims, testimonials, affiliate copy, and a discount alone are not enough.
Price does not change the claim standard. Bring a source for each factual statement; correct or remove claims that the source packet cannot support.
Information Required Before Release Production
- Final product name and responsible company
- Complete label or facts panel where applicable
- Ingredient amounts, serving information, directions, and warnings
- Manufacturing and certification documents for any claim used
- Primary sources for scientific or market statements
- Authorized spokesperson and quotation approval
- Exact event, public date, and supporting documentation
- Media and trademark rights
Claims We Will Not Force Through
- Disease-treatment, cure, prevention, or diagnosis claims without lawful authority
- Guaranteed weight, pain, sexual, cognitive, metabolic, or other health outcomes
- Fabricated physician, celebrity, customer, or media endorsements
- Unsupported “clinically proven,” “FDA approved,” “safe,” or “side-effect free” statements
- Research transferred from an ingredient or different product as proof of the finished product
- Fake scarcity, sales figures, certifications, partnerships, or study results
DO IT YOURSELF
Check Your Supplement Announcement Before You Buy Distribution
Before paying for a wire, answer one question: can a publisher verify this story? You can do the first pass yourself. Start with a real company event and the facts you can prove. A product pitch, discount, or unsupported health outcome is not enough for a standard news release.
- Name the news and reader. Write one sentence about what changed and when. Then identify the buyer or stakeholder who needs that information and the question they would search for.
- Collect the source packet. Save the exact product label, ingredient amounts, directions, warnings, company identity, event date, certificates or research you plan to cite, quote permissions, media rights, and the page the reader should visit.
- Test every claim. Mark each sentence as a verifiable product fact, a sourced research statement, a permitted quotation, or an unsupported assertion. Do not transfer a study about one ingredient to the finished product as if it proved the product’s effects.
- Build a factual angle. Connect the event to one useful reader question. Use a clear headline, company attribution, specific evidence, and a media contact. Keep sales claims out of an ordinary news release.
- Check the publisher’s current rules. A route can hold, edit, or reject a release even after you approve the copy. Confirm category eligibility, claim restrictions, links, images, and current submission terms before spending money.
- Approve and save the exact version. Have the owner of the facts and every quoted person review the final text. Keep the approved copy and source packet so publisher questions can be answered without inventing support.
Your ready-to-submit packet: one approved release, its exact source documents, authorized quotes and media, a media contact, the chosen reader destination, and a route whose current rules fit the subject. If a core fact cannot be supported, fix the story before buying distribution.
Next, use the DIY release outline and the DIY distribution sequence. If you want MBK to assess the search opportunity, evidence, news angle, and eligible route and manage submission, compare the supplement prices and request a fit check before paying. Neither path guarantees publisher acceptance or approval of unsupported claims.
Acceptance and Refund Policy
If MBK develops an eligible release, compliant publisher-requested revisions and resubmission are included. If we ultimately cannot obtain acceptance on the purchased route, we refund the complete production-and-distribution package.
If you provide the copy and it is declined, you may revise and resubmit or receive a full refund of the distribution charge. No publication means no distribution charge.
Publisher approval always remains with the publisher. We do not guarantee coverage, rankings, backlinks, traffic, leads, sales, medical acceptance, or regulatory compliance.
Do Not Pay for Distribution Until the Evidence Has a Path.
We qualify the company, product, announcement, evidence, and route before exposing a high-scrutiny checkout.